V de Beco
Overview
Explore the profile of V de Beco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Beco V, LE Bars D, Scherrmann J
Ann Pharm Fr
. 2008 Apr;
66(1):60-5.
PMID: 18435989
Positron emission tomography (PET) is a recent and expanding functional nuclear imaging technique. Its extensive development is related to the radiophysical properties fluorine 18 (18F) (weak energy of positron, sufficiently...
2.
Cassinat B, Laguillier C, Gardin C, de Beco V, Burcheri S, Fenaux P, et al.
Leukemia
. 2007 Aug;
22(2):452-3.
PMID: 17713549
No abstract available.
3.
Montravers F, Kerrou K, Grahek D, Zerbib E, Mabille L, Younsi N, et al.
Presse Med
. 2002 Nov;
31(33):1560-8.
PMID: 12422485
COLORECTAL CANCERS: FDG-PET is a very effective tool in the follow-up of colorectal cancer for the early detection of recurrences, the search for other localisations in case of resectable lesions...
4.
Talbot J, Grahek D, Kerrou K, Younsi N, de Beco V, Petegnief Y, et al.
Gynecol Obstet Fertil
. 2002 Jan;
29(11):775-98.
PMID: 11770272
Although gynaecological cancers are not currently part of the clinical indications in the French registration for [18F]-fluoro-2-deoxyglucose (FDG), various studies indicate in this context a potential clinical benefit of imaging...
5.
Montravers F, Grahek D, Kerrou K, de Beco V, Younsi N, Talbot J
Gastroenterol Clin Biol
. 2001 Jul;
25(4 Suppl):B191-6.
PMID: 11449161
No abstract available.
6.
Bousson V, Moretti J, Weinmann P, Safi N, Tamgac F, Groiselle C, et al.
J Nucl Med
. 2000 Nov;
41(11):1801-7.
PMID: 11079486
Unlabelled: The purpose of the study was to evaluate the performance of dual-head coincidence gamma camera imaging using FDG in association with serum marker assays in identifying lung carcinoma in...
7.
Oliver D, Dormehl I, Louw W, Kilian E, de Beco V, Morretti J
Arzneimittelforschung
. 2000 Sep;
50(8):758-64.
PMID: 10994161
The brain imaging radiopharmaceutical, 99mTechnetium ethyl cysteinate dimer (99mTc-ECD, 99mTc-bicisate) is the most recent addition to the available set of radiopharmaceuticals for measuring cerebral blood flow. Ideally radiotracers should be...
8.
Cordobes M, Moretti J, de Beco V, Benazzouz F, Starzec A
Nucl Med Commun
. 1999 Jul;
20(5):433-7.
PMID: 10404528
It is well established that accumulation of 99Tcm-sestamibi (99Tcm-MIBI) is much higher in sensitive than multidrug-resistant tumour cells expressing the permeability glycoprotein 170 (Pgp 170) as well as a multidrug-resistance...
9.
Moretti J, Duran Cordobes M, Starzec A, de Beco V, Vergote J, Benazzouz F, et al.
J Nucl Med
. 1998 Jul;
39(7):1214-8.
PMID: 9669397
Unlabelled: It was reported recently that 99mTc-hexakis-2-methoxyisobutyl isonitrile (MIBI) uptake is drastically reduced in cancer cells that express the multidrug resistance (MDR) product, Pgp 170 kDa (Pgp), suggesting that 99mTc-MIBI...
10.
Berson A, de Beco V, Letteron P, Robin M, Moreau C, El Kahwaji J, et al.
Gastroenterology
. 1998 Apr;
114(4):764-74.
PMID: 9516397
Background & Aims: 4,4'-Diethylaminoethoxyhexestrol (DEAEH), amiodarone, and perhexiline cause steatohepatitis in humans. The mechanisms of these effects are unknown for DEAEH and have not been completely elucidated for amiodarone and...